Tympanoplasty graft preparation using ear drops containing polyethylene glycol, flumetasone and clioquinol

List, R.J.; Flook, Evelyn; Tay, H. L.

doi:10.1017/s0022215111001083

Cited by 1 publication

(1 citation statement)

References 5 publications

(15 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another application of Locacorten Vioform has been more recently described. Describing a new technique for tympanoplasty graft preparation, List, et al [ 14 ] recommend immersing a perichondral graft in Locacorten Vioform after harvest. The advantage they report is a stiffening of the graft, which increases the ease of its manipulation for an underlay technique.…”

Section: Discussionmentioning

confidence: 99%

Locacorten Vioform Ototoxicity Upon Guinea Pig Middle Ear Application

Woods

Saliba

2018

J Audiol Otol

View full text Add to dashboard Cite

Background and ObjectivesLocacorten Vioform (Novartis UK) is frequently prescribed for otomycosis. Its component, Clioquinol, also has anti-bacterial properties. Up to this point, its ototoxic potential has not been evaluated. Our objective aims to evaluate Locacorten Vioform’s potential ototoxicity when applied directly to the middle ear cavity. Materials and MethodsWe performed an experimental prospective animal study in our animal research center with 20 Hartley guinea pigs divided into 2 groups. The first group (experimental) was treated with Locacorten Vioform in one ear and with a physiologic saline solution in the other. The second group (positive control) was treated with concentrated gentamycin in one ear and physiologic saline in the other. Auditory brainstem response measurements were obtained before and after three sets of injections. Statistics were analyzed using a variance analysis with repeated measures. The histological state of cochlear outer hair cells was compared between the two groups using scanning electron microscopy.ResultsAverage hearing loss in ears treated with Locacorten Vioform was 32.1 dB, compared with a 2.5 dB average loss in the saline-treated ears. Ears treated with gentamycin lost an average of 33.0 dB. There were clinically and statistically significant differences between the two ears of the guinea pigs in both groups (p<0.001). Scanning electron microscopy revealed severe pericochlear and cochlear inflammation and ossification in the Locacorten Vioform-treated ears. Gentamycin caused significant destruction of outer hair cell architecture. ConclusionsLocacorten Vioform induces a hearing loss similar to that caused by gentamycin when applied directly to the middle ear of a guinea pig model. Electron microscopy indicates a pericochlear and cochlear inflammatory reaction with ossification.

show abstract

Section: Discussionmentioning

confidence: 99%